IZumi Bio is biotechnology company focused on the application of novel technologies in cellular reprograming , including induced pluripotent stem cells and directed differantiation with the mission of creating new therapeutics.
Funding Rounds (1) - $20MUpdate
|Jun 15, 2011||Xconomy - iPierian Shakeup Continues, as Chairman Corey Goodman, Scientist Doug Melton Exit Stem Cell Startup|
|Jul 8, 2010||Xconomy - iPierian Garners $22,000,000 Series B Financing|
|Jun 17, 2010||Xconomy - iPierian, With Harvard Science and Kleiner Perkins Cash, Pursues Stem Cells to Make Drugs|
|Sep 28, 2009||biocetera.com - iPierian acquired iZumi Bio|
|Apr 14, 2009||PE HUB - iZumi Bio Raises $20 Million|
|Apr 14, 2009||Venture Beat - iZumi raises $20 million for stem-cell development|
951 Gateway Blvd.
South San Francisco, CA 94080